Cantor Fitzgerald Brokers Boost Earnings Estimates for CATX
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Analysts at Cantor Fitzgerald raised their FY2025 earnings estimates for Perspective Therapeutics in a research report issued to clients and investors on Tuesday, May 13th. Cantor Fitzgerald analyst L. Watsek now expects that the company will post earnings per share of ($1.04) for the year, up from […]
